Kuwashima Y, Uehara T, Kishi K, Shiromizu K, Matsuzawa M, Takayama S
Department of Pathology, Saitama Cancer Center, Japan.
J Cancer Res Clin Oncol. 1994;120(11):672-7. doi: 10.1007/BF01245380.
Immunohistochemical characteristics of undifferentiated carcinomas of the ovary were examined using formalin-fixed, paraffin-embedded tissues with an avidin-biotin staining approach. Eight cases were collected from the pathology files of our Institute from a total of 214 recorded malignant ovarian tumors. For immunostaining, antibodies reacting with epithelial membrane antigen (EMA), pankeratin, vimentin, CA 125, CA 19-9, carcinoembryonic antigen (CEA), alpha-fetoprotein (AFP), alpha-1-antitrypsin (AT), epidermal growth factor receptor (EGFR), c-erbB-2, bcl-2 and p53 proteins were used. All the cases examined were positive for EMA and pankeratin, specific markers for epithelial tumors, negative for the non-epithelial tumor marker, vimentin, and also positive for EGFR. Interestingly, only one case was positive for CA 125, despite it being one of the commonest reported indicators of ovarian cancer. CA 19-9 was positive in 7 cases, CEA in 5, AFP in 2, AT in 6 and c-erbB-2 protein in 4. Two cases were positive for p53 protein, and in 1 of these positive staining for bcl-2 was also observed. These results indicate that the epithelial nature is well preserved in undifferentiated ovarian carcinomas, although consistently positive reactions were not observed within the cases for some antigens. They further clearly show that a negative signal for CA 125 can not be considered to exclude the possibility of a primary ovarian tumor.
采用抗生物素蛋白-生物素染色法,利用福尔马林固定、石蜡包埋的组织,对卵巢未分化癌的免疫组化特征进行了研究。从我院病理档案中收集了8例病例,这些病例来自总共214例有记录的恶性卵巢肿瘤。免疫染色采用与上皮膜抗原(EMA)、全角蛋白、波形蛋白、CA 125、CA 19-9、癌胚抗原(CEA)、甲胎蛋白(AFP)、α1抗胰蛋白酶(AT)、表皮生长因子受体(EGFR)、c-erbB-2、bcl-2和p53蛋白反应的抗体。所有检测病例的上皮肿瘤特异性标志物EMA和全角蛋白均呈阳性,非上皮肿瘤标志物波形蛋白呈阴性,EGFR也呈阳性。有趣的是,尽管CA 125是报道的最常见的卵巢癌指标之一,但只有1例病例呈阳性。CA 19-9在7例中呈阳性,CEA在5例中呈阳性,AFP在2例中呈阳性,AT在6例中呈阳性,c-erbB-2蛋白在4例中呈阳性。2例病例p53蛋白呈阳性,其中1例同时观察到bcl-2阳性染色。这些结果表明,卵巢未分化癌的上皮性质保存良好,尽管部分抗原在病例中未观察到一致的阳性反应。结果还进一步清楚地表明,不能认为CA 125阴性就排除原发性卵巢肿瘤的可能性。